BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 31597499)

  • 1. Matched cohort study of healthcare resource utilization and costs in young children of mothers with postpartum depression in the United States.
    Moore Simas TA; Huang MY; Packnett ER; Zimmerman NM; Moynihan M; Eldar-Lissai A
    J Med Econ; 2020 Feb; 23(2):174-183. PubMed ID: 31597499
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthcare resource utilization and costs associated with postpartum depression among commercially insured households.
    Epperson CN; Huang MY; Cook K; Gupta D; Chawla A; Greenberg PE; Eldar-Lissai A
    Curr Med Res Opin; 2020 Oct; 36(10):1707-1716. PubMed ID: 32696705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare resource utilization and costs associated with patients prescribed afatinib or erlotinib as first-line therapy for EGFR mutation-positive NSCLC in the United States.
    Samuelsen C; Lim J; Golembesky A; Shrestha S; Wang L; Griebsch I
    J Med Econ; 2020 Jan; 23(1):48-53. PubMed ID: 31314630
    [No Abstract]   [Full Text] [Related]  

  • 4. Healthcare resource utilization among commercially insured patients with cold agglutinin disease in the United States.
    Su J; Bylsma LC; Jiang X; Morales Arias J; Jain N; Nordyke RJ
    J Med Econ; 2020 Aug; 23(8):902-907. PubMed ID: 32362156
    [No Abstract]   [Full Text] [Related]  

  • 5. Mothers' Mental Health Care Use After Screening for Postpartum Depression at Well-Child Visits.
    Kallem S; Matone M; Boyd RC; Guevara JP
    Acad Pediatr; 2019 Aug; 19(6):652-658. PubMed ID: 30496869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare resource utilization and cost among individuals with late-onset versus adult-onset Huntington's disease: a claims‑based retrospective cohort study.
    To TM; Ta JT; Patel AM; Arndorfer S; Abbass IM; Gandhy R
    J Med Econ; 2023; 26(1):862-870. PubMed ID: 37350423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants.
    Chowdhury R; Franchino-Elder J; Wang L; Yuce H; Wang C; Hartaigh BO
    J Med Econ; 2019 Dec; 22(12):1338-1350. PubMed ID: 31549883
    [No Abstract]   [Full Text] [Related]  

  • 8. Maternal depression symptoms and use of child health-care services at The Pelotas 2004 Birth Cohort.
    Callo-Quinte G; Del-Ponte B; Ruivo ACO; Moreira LR; Könsgen BI; Wehrmeister FC; Matijasevich A; Barros F; Dos Santos IS
    J Affect Disord; 2019 Jun; 253():303-307. PubMed ID: 31078828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthcare resource utilization and costs in the 12 months following hospitalization for respiratory syncytial virus or unspecified bronchiolitis among infants.
    Ledbetter J; Brannman L; Wade SW; Gonzales T; Kong AM
    J Med Econ; 2020 Feb; 23(2):139-147. PubMed ID: 31432723
    [No Abstract]   [Full Text] [Related]  

  • 10. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
    Bhowmik D; Hines DM; Intorcia M; Wade RL
    J Med Econ; 2018 Jun; 21(6):622-628. PubMed ID: 29571273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression, Anxiety, and Mother-Infant Bonding in Women Seeking Treatment for Postpartum Depression Before and During the COVID-19 Pandemic.
    Layton H; Owais S; Savoy CD; Van Lieshout RJ
    J Clin Psychiatry; 2021 Jul; 82(4):. PubMed ID: 34232578
    [No Abstract]   [Full Text] [Related]  

  • 13. Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA.
    Estes SJ; Soliman AM; Zivkovic M; Chopra D; Zhu X
    Adv Ther; 2020 Jun; 37(6):2777-2791. PubMed ID: 32399813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare utilization and costs of Veterans Health Administration patients with schizophrenia treated with paliperidone palmitate long-acting injection or oral atypical antipsychotics.
    Baser O; Xie L; Pesa J; Durkin M
    J Med Econ; 2015 May; 18(5):357-65. PubMed ID: 25525771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic burden of spinal muscular atrophy in the United States: a contemporary assessment.
    Droege M; Sproule D; Arjunji R; Gauthier-Loiselle M; Cloutier M; Dabbous O
    J Med Econ; 2020 Jan; 23(1):70-79. PubMed ID: 31322019
    [No Abstract]   [Full Text] [Related]  

  • 16. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Burden of illness in patients with possible Lennox-Gastaut syndrome: A retrospective claims-based study.
    Reaven NL; Funk SE; Montouris GD; Saurer TB; Story TJ
    Epilepsy Behav; 2018 Nov; 88():66-73. PubMed ID: 30241056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Real-world health plan claims analysis of differences in healthcare utilization and total cost in patients suffering from cluster headaches and those without headache-related conditions.
    Polson M; Lord TC; Evangelatos TM; Lopes M; Santaniello BL
    Am J Manag Care; 2017 Nov; 23(16 Suppl):S295-S299. PubMed ID: 29144719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.
    Li G; Zhang L; DiBernardo A; Wang G; Sheehan JJ; Lee K; Reutfors J; Zhang Q
    PLoS One; 2020; 15(9):e0238843. PubMed ID: 32915863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective database analysis of healthcare resource utilization and costs in patients who develop post-transplant lymphoproliferative disease within the first year following allogeneic hematopoietic stem cell transplants.
    Watson C; Xu H; Princic N; Sruti I; Barlev A
    J Med Econ; 2020 Oct; 23(10):1159-1167. PubMed ID: 32643493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.